Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
European Urology
|
May 10, 2016
Corrigendum re: "Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer" [Eur Urol 2016;69:223-8]
James T Kearns
Urology
|
March 21, 2022
EDITORIAL COMMENT
James T Kearns
Current Urology Reports
|
July 12, 2023
Is Active Surveillance Too Active?
James T Kearns, Brian T Helfand
Cancer
|
September 23, 2016
Prostate cancer screening: Do guidelines matter?
James T Kearns, John L Gore
Current Urology Reports
|
August 15, 2018
Improving the Specificity of PSA Screening with Serum and Urine Markers
James T Kearns, Daniel W Lin
Current Opinion in Urology
|
June 27, 2017
Prediction models for prostate cancer outcomes: what is the state of the art in 2017?
James T Kearns, Daniel W Lin
Journal of Indian Association of Pediatric Surgeons
|
September 9, 2014
Pediatric robotic urologic surgery-2014
James T Kearns, Mohan S Gundeti
European Urology Focus
|
September 2, 2022
Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice
James T Kearns, Brian T Helfand, Jianfeng Xu
European Urology
|
September 10, 2018
Reply to Runqiang Yuan's Letter to the Editor re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706-12
James T Kearns, Lisa F Newcomb, Daniel W Lin
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
September 10, 2013
Urodynamic studies in spinal cord tethering
James T Kearns, Domenic Esposito, Beverly Dooley, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
European Urology
|
May 10, 2016
Corrigendum re: "Associations Between iCOGS Single Nucleotide Polymorphisms and Upgrading in Both Surgical and Active Surveillance Cohorts of Men with Prostate Cancer" [Eur Urol 2016;69:223-8]
James T Kearns
Urology
|
March 21, 2022
EDITORIAL COMMENT
James T Kearns
Current Urology Reports
|
July 12, 2023
Is Active Surveillance Too Active?
James T Kearns, Brian T Helfand
Cancer
|
September 23, 2016
Prostate cancer screening: Do guidelines matter?
James T Kearns, John L Gore
Current Urology Reports
|
August 15, 2018
Improving the Specificity of PSA Screening with Serum and Urine Markers
James T Kearns, Daniel W Lin
Current Opinion in Urology
|
June 27, 2017
Prediction models for prostate cancer outcomes: what is the state of the art in 2017?
James T Kearns, Daniel W Lin
Journal of Indian Association of Pediatric Surgeons
|
September 9, 2014
Pediatric robotic urologic surgery-2014
James T Kearns, Mohan S Gundeti
European Urology Focus
|
September 2, 2022
Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice
James T Kearns, Brian T Helfand, Jianfeng Xu
European Urology
|
September 10, 2018
Reply to Runqiang Yuan's Letter to the Editor re: James T. Kearns, Anna V. Faino, Lisa F. Newcomb, et al. Role of Surveillance Biopsy with No Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study. Eur Urol 2018;73:706-12
James T Kearns, Lisa F Newcomb, Daniel W Lin
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
September 10, 2013
Urodynamic studies in spinal cord tethering
James T Kearns, Domenic Esposito, Beverly Dooley, et al.
Page
of 3